However, the upcoming edition of the WHO classification takes into consideration new insights regarding the allelic state of this gene to redefine a specific subtype of MDS associated with the presence of multiple alterations affecting the TP53 locus (Figure 2). The gene discussed is TP53; the disease is myelodysplastic syndrome.